MyoKardia Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
MyoKardia (MYOK) IPO Opens 10% Higher
October 29, 2015 10:48 AM EDTToday's IPO for MyoKardia (NASDAQ: MYOK) opened for trading at $11.08 after pricing 5,437,500 shares of common stock at a public offering price of $10.00 per share.
Credit Suisse Securities (USA) LLC and Cowen and Company, LLC are acting as lead book-running managers. Wells Fargo Securities is acting as book-running manager. Wedbush PacGrow is acting as co-manager.
MyoKardia is a clinical stage... More
